An interventional study of Text message notification in Childhood Influenza Vaccination and School-located Influenza Vaccination, sponsored by University of Rochester. Completed at 1 site in United States. Open to participants aged 4 Years to 19 Years. Per ClinicalTrials.gov, last updated 2018-03-12.
Sponsored by University of Rochester · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Children whose parents receive text reminders are more likely to be consented to participate in the school located influenza vaccination clinic than children whose parents do not receive text reminders.
410 studies on the registry are indexed under Respiratory Tract Diseases; 59 are open to participants now.
This study's enrollment of 18,540 is above the median of 117 across 316 interventional studies indexed under Respiratory Tract Diseases.
Browse Respiratory Tract Diseases studies →University of Rochester is the lead sponsor of 729 studies on the registry; 116 are open to participants now.
Of its 56 completed or terminated interventional studies of FDA-regulated products, 44 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Parents receive usual communication from school (paper consent packets \& automated voice mails) about SLIV
Parents receive usual communication from school (paper consent packets \& automated voice mails) about SLIV plus a series of text messages informing them about the usual communication for SLIV
Other: Text message notification
Three text messages will be sent to 50% of the parents, scheduled around the standard methods of communication
Influenza vaccination status
Vaccination status for the 2017/2018 influenza season will be assessed. The vaccination date will be recorded, as well as the provider name, to determine whether vaccine was received at the school-located influenza clinic
Time frame: Through January, 2018
Plan to share: No
No publications or documents are linked to this record.
Ran from Dec 2017 to primary completion in Dec 2017, 0 months.
Of 46 non-industry interventional studies with no phase under Respiratory Tract Diseases, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 74. This study's 0 months is below that.
Counting every sponsor, half of 52 studies reached it within 30 months; a quarter within 11 and three quarters within 74.
Respiratory Tract Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.